Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Gadwal: In a key development aimed at improving agricultural infrastructure in Alampur constituency, Dr. S.A. Sampath Kumar, ...

HYDERABAD: Sri Konda Laxman Telangana Horticultural University is formulating a strategy to supply quality seeds to horticulture farmers across the state to boost yields and enhance profits, Vice ...

Speakers at the “Dr. Neelam Sanjiva Reddy Memorial Awards-2025” hailed him as a beacon of hope for the current and future ...

K.T. Rama Rao criticizes Congress manifesto, highlighting failures in implementing promises and praises BRS achievements in ...

Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Reddy's Laboratories Limited RDY reported first-quarter fiscal 2026 earnings of 20 cents per American Depositary Share ...

Revenue grew 11.4% to Rs 8,572 crore, but the bottom line of Rs 1,418 crore missed Bloomberg’s consensus estimate of Rs 1,514 ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Q1FY26 revenues at ?12.7 billion, YoY growth of 142% and flat QoQ growth. This includes revenues from the acquired NRT business.

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...